The challenged biotech firm, NovaGen Therapeutics, faced critical monetary difficulties stemming from unsuccessful clinical trials and escalating debt. Their internal team lacked the skill to manage the https://umarxbxa623654.blog-gold.com/58448734/biotech-cfo-services-a-case-study-in-financial-turnaround